Radical Shake-Up In Store For Entire EU Pharma Legislation
Commission Proposals Tackle Regulation, Pricing, Shortages, Innovation – And Much More
Executive Summary
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
You may also be interested in...
Coronavirus Notebook: Pfizer/BioNTech On Plans For EU Vaccine Rollout, COVAX Strikes New Deals
The latest round-up from the Pink Sheet of developments relating to COVID-19.
EU Stakeholders Want More Focus On Availability Of Medicines
EU regulators have released their medicines network strategy to 2025 following a consultation that revealed broad support for its aim of ensuring the continued availability of medicines and accelerating innovation, but flagged up a number of areas where respondents wanted more clarity.
EU Stakeholders Want More Focus On Availability Of Medicines
EU regulators have released their medicines network strategy to 2025 following a consultation that revealed broad support for its aim of ensuring the continued availability of medicines and accelerating innovation, but flagged up a number of areas where respondents wanted more clarity.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: